topic: Access to Medicines

Access to medicines: Humanitarian mechanism for vaccines used for first time in Europe to counter high prices
Tuberculosis: Activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
As WHO issues critical new TB treatment recommendations, MSF calls on governments to urgently scale-up all oral treatment
Health groups appeal European Patent Office decision to uphold Gilead’s patent on hepatitis C drug
Health groups appeal European Patent Office decision to uphold Gilead’s patent on hepatitis C drug
Access to medicines: HIV and TB treatment at risk as countries gradually lose Global Fund support
Access to medicines: HIV and TB treatment at risk as countries gradually lose Global Fund support
ASEAN and India urged not to trade away people’s lives in trade agreement
ASEAN and India urged not to trade away people’s lives in trade agreement
People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India
People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India
MSF statement on resumption of EU-India FTA negotiations
MSF statement on resumption of EU-India FTA negotiations
Drug-resistant TB: “Some of our patients simply can’t wait for clinical trials”. Photo: Sydelle WIllow Smith
Drug-resistant TB: “Some of our patients simply can’t wait for clinical trials”
MSF challenges Pfizer’s monopoly on lifesaving pneumonia vaccine in Korea